Literature DB >> 23225013

Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.

Beata Sikorska1, Pawel P Liberski.   

Abstract

Transmissible spongiform encephalopathies (TSEs) or prion diseases are the names given to the group of fatal neurodegenerative disorders that includes kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker disease (GSS), fatal and sporadic familial insomnia and the novel prion disease variable protease-sensitive prionopathy (PSPr) in humans. Kuru was restricted to natives of the Foré linguistic group in Papua New Guinea and spread by ritualistic endocannibalism. CJD appears as sporadic, familial (genetic or hereditary) and infectious (iatrogenic) forms. Variant CJD is a zoonotic CJD type and of major public health importance, which resulted from transmission from bovine spongiform encephalopathy (BSE) through ingestion of contaminated meat products. GSS is a slowly progressive hereditary autosomal dominant disease and the first human TSE in which a mutation in a gene encoding for prion protein (PrP) was discovered. The rarest human prion disease is fatal insomnia, which may occur, in genetic and sporadic form. More recently a novel prion disease variable protease-sensitive prionopathy (PSPr) was described in humans.TSEs are caused by a still incompletely defined infectious agent known as a "prion" which is widely regarded to be an aggregate of a misfolded isoform (PrP(Sc)) of a normal cellular glycoprotein (PrP(c)). The conversion mechanism of PrP(c) into PrP(Sc) is still not certain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225013     DOI: 10.1007/978-94-007-5416-4_17

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  13 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  New engineered antibodies against prions.

Authors:  Nives Škrlj; Marko Dolinar
Journal:  Bioengineered       Date:  2013-08-09       Impact factor: 3.269

3.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

4.  Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old.

Authors:  Nupur Ghoshal; Arie Perry; Daniel McKeel; Robert E Schmidt; Deborah Carter; Joanne Norton; Wen-Quan Zou; Xiangzhu Xiao; Gianfranco Puoti; Silvio Notari; Pierluigi Gambetti; John C Morris; Nigel J Cairns
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Apr-Jun       Impact factor: 2.703

Review 5.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

Review 6.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

7.  Urodynamic findings in patients with Creutzfeldt-Jakob disease: a case report.

Authors:  Masashi Yano; Ryuji Sakakibara; Fuyuki Tateno; Osamu Takahashi; Haruka Nakamura; Megumi Sugiyama; Lee Fang-Ching; Syuichi Kamijima; Naoto Kamiya; Hiroyoshi Suzuki
Journal:  Int Urol Nephrol       Date:  2016-06-17       Impact factor: 2.370

8.  Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

Authors:  Sylvain Lehmann; Aroa Relano-Gines; Sarah Resina; Elsa Brillaud; Danielle Casanova; Charles Vincent; Claire Hamela; Sophie Poupeau; Mathieu Laffont; Audrey Gabelle; Constance Delaby; Maxime Belondrade; Jacques-Damien Arnaud; Maria-Teresa Alvarez; Jean-Claude Maurel; Patrick Maurel; Carole Crozet
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

9.  A novel equine-derived pericardium membrane for dural repair: A preliminary, short-term investigation.

Authors:  Roberto Centonze; Emiliano Agostini; Samantha Massaccesi; Stefano Toninelli; Letterio Morabito
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep

10.  Canine D163-PrP polymorphic variant does not provide complete protection against prion infection in small ruminant PrP context.

Authors:  Alba Marín-Moreno; Juan Carlos Espinosa; Patricia Aguilar-Calvo; Natalia Fernández-Borges; José Luis Pitarch; Lorenzo González; Juan María Torres
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.